Global Argatroban Market Growth 2023-2029

Global Argatroban Market Growth 2023-2029

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

LPI (LP Information)' newest research report, the “Argatroban Industry Forecast” looks at past sales and reviews total world Argatroban sales in 2022, providing a comprehensive analysis by region and market sector of projected Argatroban sales for 2023 through 2029. With Argatroban sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Argatroban industry.

This Insight Report provides a comprehensive analysis of the global Argatroban landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Argatroban portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Argatroban market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Argatroban and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Argatroban.

The global Argatroban market size is projected to grow from US$ 62 million in 2022 to US$ 41 million in 2029; it is expected to grow at a CAGR of 41 from 2023 to 2029.

Global Argatroban key players include Mitsubishi Tanabe Pharma, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, SANDOZ, etc. Global top four manufacturers hold a share nearly 60%.

Japan is the largest market, with a share about 35%, followed by Europe, and USA, both have a share about 55 percent.

In terms of product, Argatroban Injection is the largest segment, with a share over 70%. And in terms of application, the largest application is Heparin-induced thrombocytopenia (HIT), followed by Percutaneous Coronary Intervention, Cerebral arterial thrombosis.

This report presents a comprehensive overview, market shares, and growth opportunities of Argatroban market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Argatroban Powder

Argatroban Injection

Segmentation by application

Heparin-induced Thrombocytopenia (HIT)

Percutaneous Coronary Intervention

Cerebral Arterial Thrombosis

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Pfizer, Inc

SANDOZ

GlaxoSmithKline Plc

fresenius-kabi

Eagle Pharmaceuticals, Inc

Mitsubishi Tanabe Pharma

Teva Pharmaceutical Industries Ltd

WEST-WARD,INC

Key Questions Addressed in this Report

What is the 10-year outlook for the global Argatroban market?

What factors are driving Argatroban market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Argatroban market opportunities vary by end market size?

How does Argatroban break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.